Prot# 32101-2-05: An Open-Label, Treatment Continuation Study of 2% Nanocrystalline Silver Cream (NPI 32101) Applied Twice Daily in Children with Atopic Dermatitis Who Previously Completed a Double-Blind, Placebo-Controlled Study of NPI 32101